Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Buy
74
BOEUF Quote, Financials, Valuation and Earnings
Last price:
$19.80
Seasonality move
:
24.18%
Day range:
$19.80 - $19.80
52-week range:
$18.57 - $35.00
Dividend yield:
0%
P/E ratio:
87.59x
P/S ratio:
11.94x
P/B ratio:
14.67x
Volume:
4
Avg. volume:
221
1-year change:
-43.25%
Market cap:
$1.3B
Revenue:
$85M
EPS (TTM):
$0.23
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BOEUF
BONESUPPORT HOLDING AB
|
-- | -- | -- | -- | -- |
|
BOVNF
BioInvent International AB
|
-- | -- | -- | -- | -- |
|
BRCTF
BioArctic AB
|
-- | -- | -- | -- | -- |
|
CAMRF
Camurus AB
|
-- | -- | -- | -- | -- |
|
HNSBF
Hansa Biopharma AB
|
-- | -- | -- | -- | -- |
|
ORXOY
Orexo AB
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BOEUF
BONESUPPORT HOLDING AB
|
$19.80 | -- | $1.3B | 87.59x | $0.00 | 0% | 11.94x |
|
BOVNF
BioInvent International AB
|
$3.29 | -- | $216.4M | -- | $0.00 | 0% | 8.69x |
|
BRCTF
BioArctic AB
|
$34.74 | -- | $3.1B | 32.81x | $0.00 | 0% | 16.63x |
|
CAMRF
Camurus AB
|
$69.70 | -- | $4.2B | 53.86x | $0.00 | 0% | 17.95x |
|
HNSBF
Hansa Biopharma AB
|
$2.91 | -- | $290.2M | -- | $0.00 | 0% | 12.08x |
|
ORXOY
Orexo AB
|
$2.60 | -- | $90.2M | -- | $0.00 | 0% | 1.31x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BOEUF
BONESUPPORT HOLDING AB
|
1.33% | -0.277 | 0.06% | 3.45x |
|
BOVNF
BioInvent International AB
|
1.54% | -0.944 | 0.53% | 6.82x |
|
BRCTF
BioArctic AB
|
2.31% | 0.968 | 0.18% | 3.14x |
|
CAMRF
Camurus AB
|
2.52% | 0.192 | 0.28% | 9.80x |
|
HNSBF
Hansa Biopharma AB
|
254.41% | 1.407 | 39.58% | 1.00x |
|
ORXOY
Orexo AB
|
171.74% | -0.131 | 97.86% | 1.32x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BOEUF
BONESUPPORT HOLDING AB
|
$28.7M | $7.5M | 19.66% | 20% | 24.16% | $7.5M |
|
BOVNF
BioInvent International AB
|
-- | -$14.1M | -37.24% | -37.89% | -4030.98% | -$11.2M |
|
BRCTF
BioArctic AB
|
$12.7M | -$2.6M | 57.61% | 59.48% | -18.55% | -$2.5M |
|
CAMRF
Camurus AB
|
$54.8M | $24.9M | 21.21% | 21.63% | 41.84% | $14.2M |
|
HNSBF
Hansa Biopharma AB
|
$1.1M | -$15.5M | -135.05% | -- | -480.21% | -$9.8M |
|
ORXOY
Orexo AB
|
$11.4M | -$2.2M | -54.08% | -134.37% | -18.19% | $240.6K |
BONESUPPORT HOLDING AB vs. Competitors
-
Which has Higher Returns BOEUF or BOVNF?
BioInvent International AB has a net margin of 11.73% compared to BONESUPPORT HOLDING AB's net margin of -3891.55%. BONESUPPORT HOLDING AB's return on equity of 20% beat BioInvent International AB's return on equity of -37.89%.
Company Gross Margin Earnings Per Share Invested Capital BOEUFBONESUPPORT HOLDING AB92.89% $0.05 $90.1M BOVNFBioInvent International AB-- -$0.21 $73.8M -
What do Analysts Say About BOEUF or BOVNF?
BONESUPPORT HOLDING AB has a consensus price target of --, signalling downside risk potential of --. On the other hand BioInvent International AB has an analysts' consensus of -- which suggests that it could fall by --. Given that BONESUPPORT HOLDING AB has higher upside potential than BioInvent International AB, analysts believe BONESUPPORT HOLDING AB is more attractive than BioInvent International AB.
Company Buy Ratings Hold Ratings Sell Ratings BOEUFBONESUPPORT HOLDING AB0 0 0 BOVNFBioInvent International AB0 0 0 -
Is BOEUF or BOVNF More Risky?
BONESUPPORT HOLDING AB has a beta of 0.680, which suggesting that the stock is 32.024% less volatile than S&P 500. In comparison BioInvent International AB has a beta of 6.936, suggesting its more volatile than the S&P 500 by 593.641%.
-
Which is a Better Dividend Stock BOEUF or BOVNF?
BONESUPPORT HOLDING AB has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. BioInvent International AB offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BONESUPPORT HOLDING AB pays -- of its earnings as a dividend. BioInvent International AB pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BOEUF or BOVNF?
BONESUPPORT HOLDING AB quarterly revenues are $30.9M, which are larger than BioInvent International AB quarterly revenues of $348.9K. BONESUPPORT HOLDING AB's net income of $3.6M is higher than BioInvent International AB's net income of -$13.6M. Notably, BONESUPPORT HOLDING AB's price-to-earnings ratio is 87.59x while BioInvent International AB's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BONESUPPORT HOLDING AB is 11.94x versus 8.69x for BioInvent International AB. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BOEUFBONESUPPORT HOLDING AB11.94x 87.59x $30.9M $3.6M BOVNFBioInvent International AB8.69x -- $348.9K -$13.6M
-
Which has Higher Returns BOEUF or BRCTF?
BioArctic AB has a net margin of 11.73% compared to BONESUPPORT HOLDING AB's net margin of -65.15%. BONESUPPORT HOLDING AB's return on equity of 20% beat BioArctic AB's return on equity of 59.48%.
Company Gross Margin Earnings Per Share Invested Capital BOEUFBONESUPPORT HOLDING AB92.89% $0.05 $90.1M BRCTFBioArctic AB90.84% -$0.10 $214.3M -
What do Analysts Say About BOEUF or BRCTF?
BONESUPPORT HOLDING AB has a consensus price target of --, signalling downside risk potential of --. On the other hand BioArctic AB has an analysts' consensus of -- which suggests that it could fall by --. Given that BONESUPPORT HOLDING AB has higher upside potential than BioArctic AB, analysts believe BONESUPPORT HOLDING AB is more attractive than BioArctic AB.
Company Buy Ratings Hold Ratings Sell Ratings BOEUFBONESUPPORT HOLDING AB0 0 0 BRCTFBioArctic AB0 0 0 -
Is BOEUF or BRCTF More Risky?
BONESUPPORT HOLDING AB has a beta of 0.680, which suggesting that the stock is 32.024% less volatile than S&P 500. In comparison BioArctic AB has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BOEUF or BRCTF?
BONESUPPORT HOLDING AB has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. BioArctic AB offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BONESUPPORT HOLDING AB pays -- of its earnings as a dividend. BioArctic AB pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BOEUF or BRCTF?
BONESUPPORT HOLDING AB quarterly revenues are $30.9M, which are larger than BioArctic AB quarterly revenues of $14M. BONESUPPORT HOLDING AB's net income of $3.6M is higher than BioArctic AB's net income of -$9.1M. Notably, BONESUPPORT HOLDING AB's price-to-earnings ratio is 87.59x while BioArctic AB's PE ratio is 32.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BONESUPPORT HOLDING AB is 11.94x versus 16.63x for BioArctic AB. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BOEUFBONESUPPORT HOLDING AB11.94x 87.59x $30.9M $3.6M BRCTFBioArctic AB16.63x 32.81x $14M -$9.1M
-
Which has Higher Returns BOEUF or CAMRF?
Camurus AB has a net margin of 11.73% compared to BONESUPPORT HOLDING AB's net margin of 33.97%. BONESUPPORT HOLDING AB's return on equity of 20% beat Camurus AB's return on equity of 21.63%.
Company Gross Margin Earnings Per Share Invested Capital BOEUFBONESUPPORT HOLDING AB92.89% $0.05 $90.1M CAMRFCamurus AB91.93% $0.34 $449M -
What do Analysts Say About BOEUF or CAMRF?
BONESUPPORT HOLDING AB has a consensus price target of --, signalling downside risk potential of --. On the other hand Camurus AB has an analysts' consensus of -- which suggests that it could fall by --. Given that BONESUPPORT HOLDING AB has higher upside potential than Camurus AB, analysts believe BONESUPPORT HOLDING AB is more attractive than Camurus AB.
Company Buy Ratings Hold Ratings Sell Ratings BOEUFBONESUPPORT HOLDING AB0 0 0 CAMRFCamurus AB0 0 0 -
Is BOEUF or CAMRF More Risky?
BONESUPPORT HOLDING AB has a beta of 0.680, which suggesting that the stock is 32.024% less volatile than S&P 500. In comparison Camurus AB has a beta of 0.933, suggesting its less volatile than the S&P 500 by 6.658%.
-
Which is a Better Dividend Stock BOEUF or CAMRF?
BONESUPPORT HOLDING AB has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Camurus AB offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BONESUPPORT HOLDING AB pays -- of its earnings as a dividend. Camurus AB pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BOEUF or CAMRF?
BONESUPPORT HOLDING AB quarterly revenues are $30.9M, which are smaller than Camurus AB quarterly revenues of $59.6M. BONESUPPORT HOLDING AB's net income of $3.6M is lower than Camurus AB's net income of $20.2M. Notably, BONESUPPORT HOLDING AB's price-to-earnings ratio is 87.59x while Camurus AB's PE ratio is 53.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BONESUPPORT HOLDING AB is 11.94x versus 17.95x for Camurus AB. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BOEUFBONESUPPORT HOLDING AB11.94x 87.59x $30.9M $3.6M CAMRFCamurus AB17.95x 53.86x $59.6M $20.2M
-
Which has Higher Returns BOEUF or HNSBF?
Hansa Biopharma AB has a net margin of 11.73% compared to BONESUPPORT HOLDING AB's net margin of -481.29%. BONESUPPORT HOLDING AB's return on equity of 20% beat Hansa Biopharma AB's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BOEUFBONESUPPORT HOLDING AB92.89% $0.05 $90.1M HNSBFHansa Biopharma AB34.72% -$0.18 $38.6M -
What do Analysts Say About BOEUF or HNSBF?
BONESUPPORT HOLDING AB has a consensus price target of --, signalling downside risk potential of --. On the other hand Hansa Biopharma AB has an analysts' consensus of -- which suggests that it could fall by --. Given that BONESUPPORT HOLDING AB has higher upside potential than Hansa Biopharma AB, analysts believe BONESUPPORT HOLDING AB is more attractive than Hansa Biopharma AB.
Company Buy Ratings Hold Ratings Sell Ratings BOEUFBONESUPPORT HOLDING AB0 0 0 HNSBFHansa Biopharma AB0 0 0 -
Is BOEUF or HNSBF More Risky?
BONESUPPORT HOLDING AB has a beta of 0.680, which suggesting that the stock is 32.024% less volatile than S&P 500. In comparison Hansa Biopharma AB has a beta of 0.402, suggesting its less volatile than the S&P 500 by 59.764%.
-
Which is a Better Dividend Stock BOEUF or HNSBF?
BONESUPPORT HOLDING AB has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hansa Biopharma AB offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BONESUPPORT HOLDING AB pays -- of its earnings as a dividend. Hansa Biopharma AB pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BOEUF or HNSBF?
BONESUPPORT HOLDING AB quarterly revenues are $30.9M, which are larger than Hansa Biopharma AB quarterly revenues of $3.2M. BONESUPPORT HOLDING AB's net income of $3.6M is higher than Hansa Biopharma AB's net income of -$15.6M. Notably, BONESUPPORT HOLDING AB's price-to-earnings ratio is 87.59x while Hansa Biopharma AB's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BONESUPPORT HOLDING AB is 11.94x versus 12.08x for Hansa Biopharma AB. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BOEUFBONESUPPORT HOLDING AB11.94x 87.59x $30.9M $3.6M HNSBFHansa Biopharma AB12.08x -- $3.2M -$15.6M
-
Which has Higher Returns BOEUF or ORXOY?
Orexo AB has a net margin of 11.73% compared to BONESUPPORT HOLDING AB's net margin of -33.67%. BONESUPPORT HOLDING AB's return on equity of 20% beat Orexo AB's return on equity of -134.37%.
Company Gross Margin Earnings Per Share Invested Capital BOEUFBONESUPPORT HOLDING AB92.89% $0.05 $90.1M ORXOYOrexo AB92.89% -$0.12 $29M -
What do Analysts Say About BOEUF or ORXOY?
BONESUPPORT HOLDING AB has a consensus price target of --, signalling downside risk potential of --. On the other hand Orexo AB has an analysts' consensus of -- which suggests that it could fall by --. Given that BONESUPPORT HOLDING AB has higher upside potential than Orexo AB, analysts believe BONESUPPORT HOLDING AB is more attractive than Orexo AB.
Company Buy Ratings Hold Ratings Sell Ratings BOEUFBONESUPPORT HOLDING AB0 0 0 ORXOYOrexo AB0 0 0 -
Is BOEUF or ORXOY More Risky?
BONESUPPORT HOLDING AB has a beta of 0.680, which suggesting that the stock is 32.024% less volatile than S&P 500. In comparison Orexo AB has a beta of 0.861, suggesting its less volatile than the S&P 500 by 13.934%.
-
Which is a Better Dividend Stock BOEUF or ORXOY?
BONESUPPORT HOLDING AB has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Orexo AB offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BONESUPPORT HOLDING AB pays -- of its earnings as a dividend. Orexo AB pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BOEUF or ORXOY?
BONESUPPORT HOLDING AB quarterly revenues are $30.9M, which are larger than Orexo AB quarterly revenues of $12.2M. BONESUPPORT HOLDING AB's net income of $3.6M is higher than Orexo AB's net income of -$4.1M. Notably, BONESUPPORT HOLDING AB's price-to-earnings ratio is 87.59x while Orexo AB's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BONESUPPORT HOLDING AB is 11.94x versus 1.31x for Orexo AB. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BOEUFBONESUPPORT HOLDING AB11.94x 87.59x $30.9M $3.6M ORXOYOrexo AB1.31x -- $12.2M -$4.1M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 30
Galecto, Inc. [GLTO] is down 12.13% over the past day.
Sell
20
SMX alert for Dec 29
SMX (Security Matters) Plc [SMX] is down 27.67% over the past day.
Sell
29
CDNAF alert for Dec 30
Canadian Tire Corp. Ltd. [CDNAF] is up 11.94% over the past day.
